Your browser version may not work well with NCBI's Web applications. More information here...
1: Vasc Health Risk Manag. 2007;3(5):701-9.Click here to read Links

Management of intracerebral hemorrhage.

Sahni R, Weinberger J.

Department of Neurology, Mount Sinai School of Medicine, NewYork, NY 10029, USA. sahnir01@mssm.edu

Currently, intracerebral hemorrhage (ICH) has the highest mortality rate of all stroke subtypes (Counsell et al 1995; Qureshi et al 2005). Hematoma growth is a principal cause of early neurological deterioration. Prospective and retrospective studies indicate that up to 38% hematoma expansion is noted within three hours of ICH onset and that hematoma volume is an important predictor of 30-day mortality (Brott et al 1997; Qureshi et al 2005). This article will review current standard of care measures for ICH patients and new research directed at early hemostatic therapy and minimally invasive surgery.

PMID: 18078021 [PubMed - indexed for MEDLINE]

PMCID: PMC2291314